Novelgen
Find Us
← Back to list
Big-name investors pour $100M into DNA therapeutics developer Seawolf

Big-name investors pour $100M into DNA therapeutics developer Seawolf

BioPharma DiveJacob BellNovember 16, 2026
The startup, which also just disclosed an up to $1.2 billion partnership with Sanofi, is backed by Versant, MPM BioImpact, Eli Lilly and Novartis venture arm.
Read original article
← Back to list